| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.21 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |